Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-22

Clinical Trial Update: The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating milnacipran for sleep disturbance in fibromyalgia completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Milnacipran (milnacipran)

Snippet

Sponsor: Mansoor Ahmed M.D. | Conditions: Sleep Disorders, Fibromyalgia | Phase 4 | Status: COMPLETED | Results posted: 2015-07-22